NCT00178958 Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia Status COMPLETED Phase NA
NCT00178932 Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors Status COMPLETED Phase NA
NCT00177567 Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study Status COMPLETED Phase PHASE4
NCT00176202 Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar Status COMPLETED Phase PHASE3
NCT00169052 Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People Status COMPLETED Phase NA
NCT00167310 Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation Status COMPLETED Phase PHASE2
NCT00159796 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009) Status COMPLETED Phase PHASE3
NCT00159783 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) Status COMPLETED Phase PHASE3
NCT00159744 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008) Status COMPLETED Phase PHASE3
NCT00158990 Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression. Status COMPLETED Phase PHASE3
NCT00154323 The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States. Status COMPLETED Phase PHASE4
NCT00150605 Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00150553 Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00145509 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786) Status COMPLETED Phase PHASE3
NCT00145470 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017) Status COMPLETED Phase PHASE3
NCT00143182 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED) Status COMPLETED Phase PHASE3